Search for
Login | Username Password Forgot? | Email: | Create Account
Health / Medical / Fitness | Popularity: 0 | Entries: 4322 | Modified: 3h 34m ago | | Add to My Feeds
SAN FRANCISCO, CA (MARKET WIRE) AmStem Corporation (OTCBB: AMST), a world leader in stem cell research using stem cells collected from the umbilical cord immediately after birth, announced today the launch of a new consumer-based study of its flagship cosmeceutical product SteMixx™.


More from Market Wire - Medical and Healthcare: Health and Nutrition


^ Back To Top